Israel-Premier Tech withdraw from Tour of Flanders for medical reasons
WorldTour squad already depleted by illness and injury hit by second Covid positive
Israel-Premier Tech will not ride the Tour of Flanders on Sunday due to illness and injury, with the team unable to field enough healthy riders.
In a press statement on Friday morning, Israel-Premier Tech's general manager Kjell Carlström said that the decision had been made "out of respect for the race and the rest of the peloton" after two Covid cases in the camp.
The team will also not be riding next Wednesday’s Scheldeprijs, which is also organised by Flanders Classics.
Illness continues to impact the professional peloton, depleting teams and affecting riders. On Thursday, Jumbo-Visma said it was "unlikely" that Wout van Aert would take to the start line on Sunday.
Patrick Lefevere, Quick-Step Alpha Vinyl's boss, said on Thursday that 11 of his riders were currently out of action due to bad health.
>>> Paris-Sneeze: The tale of a Race to the Sun struck by illness
Israel-Premier Tech have been badly affected by illness in recent weeks, and were only able to fill five of the seven spots available to them at Dwars door Vlaanderen on Wednesday.
Get The Leadout Newsletter
The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!
In the run up to the Tour of Flanders, the team have not managed any notable results, with their best rider finishing 38th at the E3 Saxo Bank Classic, 55th at Gent-Wevelgem, and 42nd at Dwars. They have managed just won win this season, a stage of Gran Camiño through Michael Woods.
With the squad also riding in Spain this weekend, at the GP Miguel Indurain, and then at Itzulia Basque Country from Monday, they do not have enough riders to cover all the races.
“This is a very regrettable situation and we are extremely disappointed to have to withdraw from Ronde van Vlaanderen," Carlström said. "This decision has not been taken lightly but we feel this is our only option at this stage. It is no secret we have had covid and other illness and also crash-induced injuries wiping out the majority of our riders at one stage or another in recent weeks.
"Right now, we have very few healthy riders who could take to the start line, but they are now close contacts, and it is out of respect for the race and the rest of the peloton, that we are making this decision. It is our duty of care to the other teams to not be willingly sending riders who have been exposed to covid into a race."
There have been very few acknowledged cases of covid in the peloton, with 'normal' illness impacting riders the most. Back in February, whole teams were forced to withdraw from the Volta a la Comunitat Valenciana due to Covid cases.
Carlström said that not racing Flanders would allow his riders to "hit the reset button". Paris-Roubaix is a week later than usual this year, so the team might still be able to make an impact in the north of Europe this spring.
“By withdrawing from the race, we are allowing our cobbled classics riders to recover and hit the reset button," he said. "No one is more disappointed than us but hopefully, this decision will allow us to save the remainder of the spring season and get back on track.”
Thank you for reading 20 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Adam is Cycling Weekly’s news editor – his greatest love is road racing but as long as he is cycling, he's happy. Before joining CW in 2021 he spent two years writing for Procycling. He's usually out and about on the roads of Bristol and its surrounds.
Before cycling took over his professional life, he covered ecclesiastical matters at the world’s largest Anglican newspaper and politics at Business Insider. Don't ask how that is related to riding bikes.
-
Has cycling's most affordable pro bike brand just launched its aero machine?
Van Rysel set to equip Decathlon AG2R La Mondiale with new RCR-F in 2025
By Tom Thewlis Published
-
Even if you ride a lot, here's why you shouldn't skip leg day at the gym
Think your legs get enough exercise? A little gym time can unlock big strength and performance gains.
By Greg Kaplan Published
-
'I have to pinch myself and figure out if it's real or not, especially after all the s**t in the past': Stevie Williams ahead of World Championships debut
Welshman looking to end best ever year on a high in Zurich after Tour down Under, Flèche Wallonne and Tour of Britain Men victories
By Tom Thewlis Published
-
Joe Blackmore, young British winning machine, promoted to senior Israel-Premier Tech team early
Winner of Liège-Bastogne-Liège U23 and three stage races moves up to ProTeam months early
By Adam Becket Published
-
Israel-Premier Tech to tackle Paris-Roubaix on gravel bikes
Team will ride the Factor Ostro Gravel in Sunday’s cobbled Monument
By Tom Thewlis Published
-
Elisa Longo Borghini pips Kasia Niewiadoma on the line to win second Tour of Flanders
In-form Italian praises Lidl-Trek team after repeating feat she achieved in 2015
By Tom Davidson Published
-
'It's one of the hardest races I've ever done' - Mathieu van der Poel on his historic Tour of Flanders victory
World champion becomes seventh man in history to win the race three times
By Tom Davidson Published
-
Mathieu van der Poel wins record-equalling third Tour of Flanders with 45km attack
Dutchman pulls off audacious long-range coup to claim Monument victory
By Tom Davidson Published
-
Wout van Aert’s Classics dreams go up in smoke, but all is not lost for Visma-Lease a Bike
Attention turns to another promising squad member after their talisman is ruled out of Tour of Flanders, Paris-Roubaix and Amstel-Gold Race with 'several fractures'
By Tom Thewlis Published
-
Wout van Aert 'in a good place' ahead of Tour of Flanders despite Visma-Lease a Bike illness and injury crisis
Loss of Christophe Laporte and Dylan van Baarle 'a big blow' says DS Grischa Niermann as team builds for Monument double header
By Tom Thewlis Published